This report aims to provide insights into the global Transfection
Reagents and Equipment Market. Details on regional markets for these segments
are also presented in this report. In addition, leading players in the market
are profiled to study their product offerings and understand the strategies
undertaken by them to be competitive in this market.
Target Audience
for this Report:
# Biopharmaceutical
companies
# Biotechnology
companies
# Transfection
equipment, reagent, and kit manufacturing companies
# Suppliers and
distributors of transfection reagents
# Research
institutes
# Academic
centers
# Venture
capitalists
Looking Out for
More Details | Don’t Hesitate to Download the PDF
Brochure@
Factors
Influencing Global Growth:-
This growth can be attributed to factors such as
advancements in transfection technology, global alliances among leading
research institutes to trigger drug discovery, increase in R&D spending and
research activities by pharmaceutical and biotechnology companies, increase in
demand for synthetic genes, and rising incidence of cancer.
Moreover, development of large scale transfections,
rising demand of protein therapeutics, and emerging markets across India and
China are likely to create opportunities for players operating in the market.
Restraints:
# Selective
Effectiveness of Transfection Reagents
# Home Brew Reagents
Restrict Sale of Commercial Kits
# High Cost of
Transfection Reagents
Opportunities:
# Large-Scale
Transfections
# High-Growth
Opportunities in Asian Market
Challenges:
# Transfection in
Hard-To-Transfect Cells
# Cytotoxicity in
Transfection - A Major Concern
Monetary
Growth Expectations, Globally:
This report studies the global transfection
reagents and equipment market from 2016 to 2021. This market is expected to
reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of
7.5% during the forecast period.
Geographical Growth Scenario:
On the basis of region, the global transfection reagents and
equipment market is divided into North America, Europe, Asia-Pacific, and Rest
of the World (RoW).
In 2016, North America is poised to account for the largest
share of the market, followed by Europe and Asia-Pacific. However, the
Asia-Pacific market is slated to grow at the highest CAGR during the forecast
period and serve as a major revenue pocket for companies offering transfection
reagents and equipment.
Leading Market Players:
# Thermo Fisher Scientific
Inc. (U.S.)
# Promega Corporation (U.S.)
# Hoffmann-La Roche Ltd.
(Switzerland)
# QIAGEN N.V. (Netherlands) and many more…
No comments:
Post a Comment